Table 3.

Outcomes.

Variable	Entire cohort	2008–2009	2010–2011	2012–2014
30 day survival	133 (90.5%)	36 (92%)	37 (94%)	60 (94%)	0.2
1 yr survival	122 (83%)	33 (85%)	36 (90%)	53 (82%)	0.3
2 yr survival	104 (71%)	27 (69%)	29 (73%)	48 (75%)	0.2
Stroke	7 (4.7%)	3 (8%)	2 (5%)	2 (3%)	0.4
Vascular complications	18 (12%)	7 (17%)	6 (15%)	5 (8%)	0.15
Pacemaker	20 (13.6%)	6 (15%)	7 (18%)	7 (11%)	0.5
Ejection fraction	50 ± 8	50 ± 8	51 ± 9	49 ± 8	0.4
AR	0.9 ± 0.7	1.1 ± 0.7	1.2 ± 0.8	0.8 ± 0.6	0.2
MR	1.0 ± 0.8	1.2 ± 0.8	1.1 ± 0.6	0.9 ± 0.6	0.6
Improvement in creatinine	9.2%	8%	9%	10%	0.2

Data is expressed as mean ± standard deviation or number of patients (%).

AR is Aortic Regurgitation; MR is Mitral Regurgitation; EF measured by Simpsons.

Average creatinine improvement by discharge.